Statins crush early seizure risk poststroke
July 18, 2019
BANGKOK – Statin initiation upon hospitalization for acute ischemic stroke was linked to a major antiseizure benefit in a Japanese study.
Higher omega-3 fatty acid levels cut heart failure risk
July 10, 2019
A large, multi-ethnic cohort study shows significantly higher levels of EPA in adults without heart failure.
Lipoprotein(a) levels can guide CV risk assessment and treatment
June 5, 2019
High levels of Lp(a) are an independent risk factor for atherosclerotic cardiovascular disease and could be used to guide risk assessment and treatment.
SGLT2 inhibitors prevent HF hospitalization regardless of baseline LVEF
May 9, 2019
NEW ORLEANS – “At least in my mind, we have more than enough evidence at this point to say that SGLT2 inhibitors are effective in preventing heart failure,” Dr. Mikhail Kosiborod said.
Poor response to statins hikes risk of cardiovascular events
April 17, 2019
Patients with better outcomes were more likely to have initiated therapy with a more potent drug.
Newer antihyperglycemic drugs have distinctive CV, kidney benefits
March 12, 2019
SGLT2 inhibitors and GLP-1 RAs have different effects on cardiovascular and kidney disease outcomes in patients with type 2 diabetes.
SGLT2 inhibitors morph into HF drugs
February 7, 2019
“We’re increasingly moving to an age where these agents are actually cardiovascular drugs that happen to lower blood glucose.” – Dr. Akshay S. Desai
Statins cut vascular events in elderly patients
February 5, 2019
Analysis challenges current practice of discontinuation after age 75 years.
HDL-P subfractions may be prognostic in heart failure
January 14, 2019
Study may spur investigations into HDL particles.
AHA: Statins associated with high degree of safety
December 10, 2018
Rumors of statins’ adverse side effects are greatly exaggerated.